Predicting liver injury in paracetamol overdose patients

Predicting liver injury in paracetamol overdose patients
The Liverpool team identified proteins and a strand of ribonucleic acid that may help develop a blood-based test to predict risk of liver injury.

Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.

Paracetamol overdose is one of the most frequent cases of hospital admissions, accounting for approximately 90,000 hospital attendances per year in the UK and almost 47,000 bed days in England alone.  Overdose of the drug can result in liver damage, and in severe cases death.

Measuring biomarkers

The Liverpool team, in collaboration with the Royal Infirmary Edinburgh, the National Poisons Information Service, and Novartis, have identified proteins and a strand of ribonucleic acid (RNA) that may help in the future development of a blood-based test at hospitals to predict a patient's risk of .

These molecules, or biomarkers, are found in the liver, but when the die following paracetamol overdose, they spill out into the blood where scientists can measure them to give an indication of the level of injury to the liver.

Researchers, based at the University's Medical Research Council's (MRC) Centre for Drug Safety Science, showed that the biomarkers were more sensitive and accurate compared to current clinical methods and could predict the likelihood of eight hours after paracetamol overdose, a point at which indicators used today are ineffective.

Dr Dan Antoine, from the Centre for Science, said: "Clinicians work hard to treat paracetamol overdose patients as quickly as possible, but it is difficult to get the correct measure of treatment without a highly sensitive test that can predict the risk of the patient developing .

"The outcome of our study shows that it could be possible to develop a new test based on biomarkers in the blood, to determine which patients are at high risk of acute liver injury and which are not.  Identifying patients in this way will make a significant impact on clinical practice, reducing the number of and the length of time patients are treated with antidote."

add to favorites email to friend print save as pdf

Related Stories

Model predicts death due to acetaminophen overdose

Feb 24, 2012

(HealthDay) -- Model for Acetaminophen-induced Liver Damage (MALD), a mathematical model that utilizes commonly obtained laboratory values, including overdose amount and time elapsed since overdose, is effective ...

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.